Glendon Capital Management’s GoHealth GOCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-42,745
Closed -$206K 26
2025
Q3
$206K Hold
42,745
0.01% 22
2025
Q2
$237K Sell
42,745
-4,960
-10% -$39.2K 0.01% 21
2025
Q1
$585K Sell
47,705
-24,256
-34% -$370K 0.03% 22
2024
Q4
$964K Hold
71,961
0.06% 21
2024
Q3
$675K Hold
71,961
0.04% 21
2024
Q2
$699K Hold
71,961
0.05% 18
2024
Q1
$756K Hold
71,961
0.06% 18
2023
Q4
$960K Hold
71,961
0.07% 19
2023
Q3
$1.04M Hold
71,961
0.1% 19
2023
Q2
$1.42M Hold
71,961
0.14% 17
2023
Q1
$1.17M Hold
71,961
0.11% 19
2022
Q4
$752K Sell
71,961
-1
-0% -$9 0.06% 20
2022
Q3
$383K Hold
71,962
0.03% 23
2022
Q2
$645K Hold
71,962
0.05% 24
2022
Q1
$1.27M Sell
71,962
-82,487
-53% -$2.57M 0.08% 23
2021
Q4
$8.78M Hold
154,449
0.46% 19
2021
Q3
$11.7M Buy
+154,449
New +$16.3M 0.69% 18

Other funds holding GOCO

Glendon Capital Management's GOCO Position: Q4 2025 in Review

Glendon Capital Management sold out of GoHealth (GOCO) in Q4 2025, closing a stake of 42,745 shares — an estimated $206K sold.

Glendon Capital Management first reported a position in GOCO in Q3 2021 and held it in 17 quarters. The position peaked at $11.7M in Q3 2021. 56 funds tracked by Wall St. Rank hold GOCO as of Q4 2025.

  • Glendon Capital Management reported no remaining GoHealth position as of Q4 2025 after selling out during the quarter.
  • Glendon Capital Management sold 42,745 GoHealth shares in Q4 2025, an estimated $206K.
  • Glendon Capital Management first reported a position in GoHealth in Q3 2021 and held it in 17 quarters.
  • Glendon Capital Management's GoHealth position peaked at $11.7M in Q3 2021.
  • 56 funds tracked by Wall St. Rank held GoHealth as of Q4 2025.

Based on Glendon Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.